InvestSMART

Microba Life Sciences Limited (ASX: MAP) - Announcements

- Current share price for MAP : $0.037

ASX company news and announcements for Microba Life Sciences Limited (MAP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Microba Life Sciences Limited (MAP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Microba Life Sciences Limited (MAP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Microba Life Sciences Limited (MAP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$27 Investor Presentation 6 Nov 2023 9:05AM $0.230 $0.037 fallen by 83.91%
$27 Ceasing to be a substantial holder 2 Nov 2023 12:39PM $0.225 $0.037 fallen by 83.56%
$27 Change in substantial holding 1 Nov 2023 4:24PM $0.225 $0.037 fallen by 83.56%
$27 Change in substantial holding 1 Nov 2023 2:02PM $0.230 $0.037 fallen by 83.91%
$27 Change of Director's Interest Notice - Richard Bund 31 Oct 2023 9:09AM $0.230 $0.037 fallen by 83.91%
$27 Change of Director's Interest Notice - Prof Ian Frazer 31 Oct 2023 9:08AM $0.230 $0.037 fallen by 83.91%
$27 Change of Director's Interest Notice - Pasquale Rombola 31 Oct 2023 9:03AM $0.230 $0.037 fallen by 83.91%
$27 Annual Report to Shareholders 30 Oct 2023 2:16PM $0.230 $0.037 fallen by 83.91%
$27 Letter to Shareholders, Notice of AGM & Proxy Form 30 Oct 2023 2:16PM $0.230 $0.037 fallen by 83.91%
$27 Application for quotation of securities - MAP 30 Oct 2023 9:32AM $0.230 $0.037 fallen by 83.91%
$27 Letter to Ineligible Shareholders 26 Oct 2023 11:55AM $0.215 $0.037 fallen by 82.79%
$27 Retail Offer opens and dispatch of Offer Booklet 26 Oct 2023 11:54AM $0.215 $0.037 fallen by 82.79%
$27 Cleansing Notice under sections 708AA(12) and 708A(9) 23 Oct 2023 9:40AM $0.320 $0.037 fallen by 88.44%
$27 Update - Proposed issue of securities - MAP 23 Oct 2023 9:28AM $0.320 $0.037 fallen by 88.44%
$27 Fully Underwritten A$20 million Entitlement Offer 23 Oct 2023 9:27AM $0.320 $0.037 fallen by 88.44%
$27 Cleansing Notice section 708AA(2)(f) & 708A(5)(e) 19 Oct 2023 9:25AM $0.320 $0.037 fallen by 88.44%
$27 Notification to Optionholders 19 Oct 2023 9:17AM $0.320 $0.037 fallen by 88.44%
$27 Excluded Information Notice 19 Oct 2023 9:16AM $0.320 $0.037 fallen by 88.44%
$27 Proposed issue of securities - MAP 19 Oct 2023 9:08AM $0.320 $0.037 fallen by 88.44%
$27 Application for quotation of securities - MAP 19 Oct 2023 9:02AM $0.320 $0.037 fallen by 88.44%
$27 Invivo Clinical Acquisition and Capital Raising Presentation 19 Oct 2023 8:55AM $0.320 $0.037 fallen by 88.44%
$27 Microba to acquire UK microbiome leader Invivo Clinical 19 Oct 2023 8:54AM $0.320 $0.037 fallen by 88.44%
$27 Q1 FY24 Quarterly Activities Report & Appendix 4C 19 Oct 2023 8:52AM $0.320 $0.037 fallen by 88.44%
$27 Trading Halt 19 Oct 2023 8:43AM $0.320 $0.037 fallen by 88.44%
$27 Date of AGM and Closing Date for Director Nominations 12 Oct 2023 9:04AM $0.310 $0.037 fallen by 88.06%

201 - 225 of 714 results

Page 9 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.